Renovo Biosciences Overview

  • Founded
  • 2001
Founded
  • Status
  • Private
  • Latest Deal Type
  • Series A

Renovo Biosciences General Information

Description

Provider of a drug discovery services intended to offer treatment for multiple sclerosis. The company's services involve uncovering novel neuroregenerative therapies, enabling healthcare providers to cure patients suffering from neurodegenerative diseases.

Contact Information

Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Primary Industry
Drug Discovery
Other Industries
Pharmaceuticals
Biotechnology
Primary Office
  • 10000 Cedar Avenue
  • Cleveland, OH 44106
  • United States
Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial
Want to dig into this profile?

We’ll help you find what you need

Learn more

Renovo Biosciences Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
1. Early Stage VC (Series A) Completed Startup
To view Renovo Biosciences’s complete valuation and funding history, request access »